Codexis, Inc.
CDXS
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvā¦ read more
Healthcare
Biotechnology
16 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.60
Price+6.67%
$0.10
1Y
Price
Market Cap
$172.098m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-42.3%
EBITDA Margin-57.1%
Net Profit Margin-87.4%
Free Cash Flow Margin-42.3%
EBITDA Margin-57.1%
Net Profit Margin-87.4%
Free Cash Flow MarginRevenue
$78.092m
+11.0%
1y CAGR+4.7%
3y CAGR-8.8%
5y CAGREarnings
-$31.990m
+27.3%
1y CAGR+24.8%
3y CAGR-13.2%
5y CAGREPS
-$0.37
+26.0%
1y CAGR+30.1%
3y CAGR-7.3%
5y CAGRBook Value
$43.234m
$129.370m
Assets$86.136m
Liabilities$72.903m
DebtDebt to Assets
56.4%
-3.3x
Debt to EBITDAFree Cash Flow
-$22.119m
+7.2%
1y CAGR+22.9%
3y CAGR-487.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company